Balancing the harms and benefits of early detection of prostate cancer
β Scribed by Pim J. van Leeuwen; David Connolly; Teuvo L. J. Tammela; Anssi Auvinen; Ries Kranse; Monique J. Roobol; Fritz H. Schroder; Anna Gavin
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 220 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Results of a Prospective Phase 2 Trial With great interest we read the article by Brown et al, who reported the results of a phase 2 study using gemcitabine and cisplatin in patients with advanced endometrial cancer. 1 Although we recognize the reported impressive activity of this regimen, we b
Men with localized, lowβrisk carcinoma of the prostate with multiple comorbidities may experience few benefits from androgen suppression therapy (AST), and probably would be better served by an active surveillance approach, with delayed AST if evidence of progression develops. A proactive position r
## BACKGROUND. The American Cancer Society National Prostate Cancer Detection Proj-(James H. Gilbaugh, Jr., M.D.); Urology Clinic ect (ACS-NPCDP) was established in 1987. The experience of the ACS-NPCDP demonof Yakima, Yakima, Washington (Mark Uhlman, strates the yield and impact of periodic exami